Clinical Trial Update: Immune Monitoring to Facilitate Belatacept Monotherapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on immune monitoring to facilitate belatacept monotherapy in kidney transplant patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunosuppression
• Kidney Transplant Rejection

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Kidney Transplant Rejection, Immunosuppression | Phase 4 | Status: COMPLETED | Results posted: 2023-12-04